Although the reduction or omission of insulin in patients with type 1 diabetes mellitus and eating disorders is associated with very high morbidity and mortality, evidence-based guidance on its treatment is needed, as standard eating disorder treatment models are not effective [79]. This evidence concerns the gene INS and type 1 diabetes mellitus.